Donut Hole Politics: Patient Assistance Under Part D
This article was originally published in RPM Report
Executive Summary
Big pharma wants to help pick up the costs for patients reaching the coverage gap under Medicare's drug benefit. Medicare's watchdogs at the Inspector General's office are skeptical, but the pharma companies are being persistent.